ethyl 2-hydroxy-4-(1-methyl-1H-pyrazol-4-yl)-4-oxobut-2-enoate, 98%, 250mg

DBD-PZ [=4-(N,N-Dimethylaminosulfonyl)-7-piperazino-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

(1R,2R,5S)-3-[(tert-butoxy)carbonyl]-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 95.0%, 1g

(2S,5S)-Methyl 5-phenylpyrrolidine-2-carboxylate hydrochloride, 98%, 100mg

1-Bromo-3-chloro-2,6-difluorobenzene, 95.0%, 1g

Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate, 95+%, 250mg

(6-Methoxypyrimidin-4-yl)methanamine hydrochloride, 98%, 100mg

Perbromothiophene 1,1-dioxide, 98%, 250mg

4-bromo-2-fluoro-4'-thiomorpholinomethyl benzophenone, 97.0%, 1g

1-(4-Chlorobenzoyl)piperidin-4-one, 95+%, 500mg

3-Benzamido-N-(2-chlorobenzyl)benzamide, 98%, 1g

2-(4-((2,5-DIFLUOROBENZYL)OXY)PHENOXY)-5-ETHOXYANILINE, 95.0%, 25mg

4-Bromo-1,8-naphthalic anhydride, 95.0%, 25g